Found: 8
Select item for more details and to access through your institution.
Functional polymorphisms in the promoter of the matrix metalloproteinase-9 ( MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2008, v. 46, n. 1, p. 57, doi. 10.1515/CCLM.2008.014
- By:
- Publication type:
- Article
Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2006, v. 44, n. 2, p. 232, doi. 10.1515/CCLM.2006.043
- By:
- Publication type:
- Article
Gene Variation in Resistant Hypertension: Multilocus Analysis of the Angiotensin 1-Converting Enzyme, Angiotensinogen, and Endothelial Nitric Oxide Synthase Genes.
- Published in:
- DNA & Cell Biology, 2011, v. 30, n. 8, p. 555, doi. 10.1089/dna.2010.1156
- By:
- Publication type:
- Article
Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension.
- Published in:
- Hypertension Research, 2013, v. 36, n. 12, p. 1067, doi. 10.1038/hr.2013.92
- By:
- Publication type:
- Article
MDR-1 C3435T polymorphism may affect blood pressure in resistant hypertensive patients independently of its effects on aldosterone release.
- Published in:
- Journal of the Renin-Angiotensin-Aldosterone System, 2014, v. 15, n. 2, p. 170, doi. 10.1177/1470320312466124
- By:
- Publication type:
- Article
Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients.
- Published in:
- Cardiovascular Diabetology, 2011, v. 10, n. 1, p. 24, doi. 10.1186/1475-2840-10-24
- By:
- Publication type:
- Article
Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 12, p. 2027, doi. 10.1007/s00228-013-1571-z
- By:
- Publication type:
- Article
Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al
- Published in:
- ESC Heart Failure, 2018, v. 5, n. 6, p. 1069, doi. 10.1002/ehf2.12355
- By:
- Publication type:
- Article